Navigation Links
Huifeng Bio-Pharmaceutical Reported Second Quarter 2010 Financial Results and Reaffirms its 2010 Guidance
Date:8/23/2010

.hfgb.cn/">http://www.hfgb.cn/

Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of the "safe-harbor" provisions of the Private Securities Litigation Reform Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that could cause the actual results of the Company to differ materially from the results expressed or implied by such statements, including changes from anticipated levels of sales, future national or regional economic and competitive conditions, changes in relationships with customers, access to capital, difficulties in developing and marketing new products, marketing existing products, customer acceptance of existing and new products, and other factors disclosed in the Company's Annual Report on Form 10K for the year ended Dec. 31, 2009 and all of the Company's subsequent Quarterly Reports on Form 10Q, especially in the "Risk Factors" sections of these reports. Accordingly, although the Company believes that the expectations reflected in such forward-looking statements are reasonable, there can be no assurance that such expectations will prove to be correct. The Company has no obligation to update the forward-looking information contained in this press release.

For more information, please contact: Investor Relations: Capital Group Communications, Inc. Mr. Kevin Fickle Tel: +1-925-330-8315 Email: Kevin@capitalgc.com Company Contact: Huifeng Bio-Pharmaceutical Technology, Inc. Mr. Steven Tong, IR Director Tel: +86-135-7211-8351 Email: Steven@xahuifeng.com
'/>"/>

SOURCE Huifeng Bio-Pharmaceutical Technology, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Huifeng Bio-Pharmaceutical Technology Announces a New Spain Order
2. Huifeng Bio-Pharmaceutical Technology Reports 26% Quarterly Revenue Increase
3. Renhuang to Launch New Bio-pharmaceutical Product - Ginseng and Deer Antler Extract
4. FDA: Rare Cases of Liver Injury Reported With Use of Xenical, Alli
5. Radiation Reduction in Heart CT Scans Reported in Study
6. Reported Use of AMAGs Feraheme (ferumoxytol) Continues To Be Low, But a Number of Nephrologists Are On the Verge of Use
7. Definitive Outcomes of Radiofrequency Ablation for Barretts Esophagus Using the HALO Ablation System Reported at the Digestive Disease Week Meeting for Gastroenterologists and Esophageal Surgeons
8. Study Reported Tadalafil Taken Once Daily Improved Erectile Function in Men with ED and Sexual Quality of Life in Couples
9. Blue Light Destroys Antibiotic-Resistant Staph Infection - Results Reported in Photomedicine and Laser Surgery Journal
10. Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma
11. Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... ,  July 22, 2014 ... of Thomson Reuters , the world,s leading ... professionals, today announced Cortellis Clinical Trials ... marked an industry-first milestone with the documentation ... providing pharmaceutical professionals with greater and quicker ...
(Date:7/22/2014)...  Neurotrope Bioscience, Inc., a subsidiary of Neurotrope, Inc. ... with the Icahn School of Medicine at ... ) to utilize its proprietary information and data package ... Niemann-Pick Type C Disease (NPC), a rare disease, mostly ... license also covers other diseases and disorders relying on ...
(Date:7/22/2014)... 22, 2014 The steady decline of ... to previously rep-friendly specialties, according to the spring ... consulting firm ZS Associates.      AccessMonitor™ ... pharmaceutical sales teams. The report examines how often ... the pharmaceutical sales reps who visit their offices. ...
Breaking Medicine Technology:Thomson Reuters Cortellis Clinical Trials Intelligence Reaches Industry Milestone with 180,000 Clinical Trials 2Thomson Reuters Cortellis Clinical Trials Intelligence Reaches Industry Milestone with 180,000 Clinical Trials 3Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 2Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 3Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 4Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 5Even traditionally rep-friendly specialists will see fewer pharmaceutical sales reps this year, according to ZS Associates 2Even traditionally rep-friendly specialists will see fewer pharmaceutical sales reps this year, according to ZS Associates 3Even traditionally rep-friendly specialists will see fewer pharmaceutical sales reps this year, according to ZS Associates 4Even traditionally rep-friendly specialists will see fewer pharmaceutical sales reps this year, according to ZS Associates 5
... Findings from an international,multicenter, randomized, double-blind, placebo-controlled Phase ... of moderate to severe,plaque psoriasis will be presented ... the World Congress of Dermatology, which takes place ... Aires, Argentina. The presentation, entitled CNTO 1275 ...
... Study Will Assess Drug,s Benefit, Alone and With Lipitor(R), ... Cholesterol and Triglycerides -, HAYWARD, Calif., Sept. 25 ... and development of novel,therapeutics for diabetes and related metabolic ... 2 trial of MBX-8025 in overweight or,obese patients with ...
Cached Medicine Technology:Pivotal Ustekinumab (CNTO 1275) Phase 3 Data to Debut at World Congress of Dermatology Meeting 2Metabolex Begins Phase 2 Trial of MBX-8025 for Treatment of Dyslipidemia 2
(Date:7/22/2014)... July 22, 2014 According to a ... care, Automobile, Aerospace & Defense, Marine and Mining) & ... East, and Rest of the world) - Forecast Analysis ... expected to grow at a CAGR 8.00% to reach ... is estimated to grow at a CAGR of 6.00% ...
(Date:7/22/2014)... July 22, 2014 Dimension One Spas’ ... 24 months on all models during the “Let’s Take ... Please visit http://www.d1spas.com/financing for more information and ... Dimension One Spas offers a wide variety of outdoor ... lights, fountains, waterfalls, music, customizable massage, and personal controls. ...
(Date:7/22/2014)... July 22, 2014 (HealthDay News) -- People who suffer ... for a rise in blood pressure, a new study ... health problems and even early death, but few studies ... may be one of the causes, according to the ... people who had been separated or divorced for about ...
(Date:7/22/2014)... has received a five-year, $3 million grant to ... neglect and maltreatment during childhood leave molecular marks ... life. , The Center for Biomarker Research and ... in collaboration with Duke University School of Medicine, ... by the National Institutes of Health, National Institute ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 BlogHer, ... for women, this year celebrates its tenth anniversary where ... Thousands of attendees, including community leaders from the new ... representing every consumer vertical, will converge in San Jose ... conversation, and a “selfiebration” of social technology. , ...
Breaking Medicine News(10 mins):Health News:Global Actuators Market Estimated to Reach $59.32 Billion by 2019 – New Report by MarketsandMarkets 2Health News:Global Actuators Market Estimated to Reach $59.32 Billion by 2019 – New Report by MarketsandMarkets 3Health News:Global Actuators Market Estimated to Reach $59.32 Billion by 2019 – New Report by MarketsandMarkets 4Health News:Sleepless Nights After Divorce May Be Tied to Blood Pressure Rise 2Health News:VCU receives grant to study molecular marks left by childhood adverse experiences 2Health News:BlogHer, Inc. Comes Home to Silicon Valley for 10th Anniversary: World’s Largest Event for Bloggers and Social Media Influencers 2Health News:BlogHer, Inc. Comes Home to Silicon Valley for 10th Anniversary: World’s Largest Event for Bloggers and Social Media Influencers 3Health News:BlogHer, Inc. Comes Home to Silicon Valley for 10th Anniversary: World’s Largest Event for Bloggers and Social Media Influencers 4
... Society Celebrates 40 Years of Specialized ... in the U.S. and Abroad April 13-19, MT LAUREL, N.J., ... of the United States, the world and Enterostomal,Therapy (ET) Nursing. The ... the beginning of the end of the,Vietnam War influenced world events. ...
... reduce body,s release of stress hormones , , MONDAY, April ... the release of stress hormones that can weaken your ... , The researchers, who previously had found that ... that mirth may be a key to better physical ...
... Nurses Association Intervention Tool Kit Reduces Patient ... Injuries/Repeat Visits and Risky Drinking, ... 10,National Alcohol Screening Day, 360 nurses in emergency departments,nationwide ... and intervention tool kit designed to address alcohol use,problems ...
... In celebration of ELLE,s 3rd,annual May green ... and spa bus that,s green inside and out ... 15, 2008 - Sunday, May 4, 2008,making one-day ... The general public will enjoy complimentary styling, mini-makeovers,beauty ...
... trials indicate that estrogen replacement therapy (ERT) may increase the ... examined whether adverse effects of ERT are related to the ... of ERT increased problems in the kidney and heart. These ... in a womans overall health. , The study, Dose-Response ...
... April 7, 2008 Penn Foster Career School,now ... skills,for working professionals. The program offerings include a ... Anatomy and Physiology, This broad overview of ... in,the health professions. Prospective nurses, medical transcriptionists, and,first ...
Cached Medicine News:Health News:WOCN: Around the World in 40 Years 2Health News:WOCN: Around the World in 40 Years 3Health News:WOCN: Around the World in 40 Years 4Health News:Heard the One About How to Beat Tension? 2Health News:Emergency Departments Nationwide Institute New Alcohol Screening and Intervention Process 2Health News:ELLE Eco-Salon & Spa Rolls Thru Southern California Offering Styling, Mini- Makeovers and Beauty Treatments 2Health News:New study finds adverse effects of estrogen replacement therapy are related to the dose 2Health News:New study finds adverse effects of estrogen replacement therapy are related to the dose 3Health News:Penn Foster Career School Offers Certificate Programs 2
... Enzyme-linked immunosorbent assays for the ... antibodies to extractable nuclear antigens ... Antibodies to Sm aid in ... erythematosus (SLE). ,RNP antibodies aid ...
... Scientific, Inc. ENA Profile-6 ELISA test system ... of IgG antibodies to Jo-1, Sm, Sm/RNP, ... When performed according to the directional insert, ... aid in the diagnosis and treatment of ...
... CIC are formed as a host defense ... by phagocytosis. If not cleared, CIC may ... response. CIC are increased in Systemic Lupus ... be involved in other autoimmune disorders as ...
... Liquid Lipid Control is intended for use ... test sample of known concentration for monitoring ... K-ASSAY Liquid Lipid Control with patient serum ... listed constituents. The user can compare observations ...
Medicine Products: